Formononetin attenuates kidney damage in type 2 diabetic rats

• Published in: Life sciences (1973) Vol. 219; pp. 109 - 121
• Main Authors: Oza, Manisha J., Kulkarni, Yogesh A.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 15.02.2019
• Subjects: Diabetes mellitus; Diabetic nephropathy; Formononetin; Oxidative stress; SIRT1; Oxidative stress; Diabetic nephropathy; SIRT1; Formononetin; Diabetes mellitus
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2019.01.013

Diabetic nephropathy is the commonly developed complication of vasculature in type 2 diabetic patients. Chronic hyperglycemia leads to nephropathy in diabetics because of the formation of excessive reactive oxygen species and advanced glycation end products which is reflected in the form of glomerulosclerosis, tubular atrophy and interstitial fibrosis. As per the various reports reduction in SIRT1 expression in kidney tissue is key factor in the development of nephropathy in diabetes because its reduction in tissue is linked with excessive formation of ROS. Formononetin is a polyphenolic compound reported for its effect on SIRT1 and ROS. Type 2 diabetes was induced in rats by diet modification using high fat diet for fifteen days prior to streptozotocin regimen (35 mg/kg, i.p.). Treatment of formononetin was started after confirmation of diabetes and continued for 16 weeks. Formononetin was administered orally to the diabetic animals at the dose of 10. 20 and 40 mg/kg. Formononetin treatment for 16 week was able to control hyperglycemia and insulin resistance in diabetic animals. It has also been reduced triglyceride and cholesterol in blood. Formononetin treatment reduced blood concentration of creatinine, blood urea nitrogen and increased albumin concentration. Formononetin treatment also enhanced creatinine clearance in diabetic animals. Oxidative stress burden was also reduced significantly after formononetin treatment along with increased SIRT1 expression in kidney tissues of diabetic animals. Formononetin is a potential molecule which increases the expression of SIRT1 in kidney tissue of diabetic. Thus formononetin is an effective molecule to control nephropathy in type 2 diabetes mellitus.